Research graph
References from The feasibility and toxicity of the second course of boron neutron capture therapy in recurrent head and neck cancer patients. Local targets link to admitted publications; unresolved targets remain external evidence.
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
10.1016/j.annonc.2020.07.011 · 2020 · External reference
Reirradiation for locally recurrent head and neck cancer: state-of-the-art and future directions
10.1016/j.semradonc.2025.02.009 · 2025 · External reference
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial
10.1016/j.radonc.2020.11.001 · 2021 · External reference
Clinical results and prognostic factors in Boron Neutron Capture Therapy for recurrent squamous cell carcinoma of the head and neck under the Japan National Health Insurance System: a retrospective study of the initial 47 patients
10.1016/j.ijrobp.2024.03.041 · 2024 · External reference
Safety of boron neutron capture therapy with Borofalan((10)B) and its efficacy on recurrent head and neck cancer: real-world Outcomes from nationwide post-marketing surveillance
10.3390/cancers16050869 · 2024 · External reference
Efficacy and safety of boron neutron capture therapy for hypopharyngeal/laryngeal cancer patients with previous head and neck irradiation
10.1016/j.radonc.2024.110382 · 2024 · External reference
Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center
10.1016/j.apradiso.2019.108961 · 2020 · External reference
Retrospective analysis of treatment-positioning accuracy and dose error in boron neutron capture therapy using a sitting-position treatment system for head and neck cancer
10.1016/j.ejmp.2024.104818 · 2024 · External reference
Evaluation of calculation accuracy and computation time in a commercial treatment planning system for accelerator-based boron neutron capture therapy
10.1007/s12194-024-00833-7 · 2024 · External reference
The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster
10.2307/3578136 · 1991 · External reference
Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo
10.1016/0360-3016(93)90533-2 · 1993 · External reference
Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin
10.2307/3578693 · 1994 · External reference
Comparative assessment of single-dose and fractionated boron neutron capture therapy
10.2307/3578951 · 1995 · External reference
Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity
10.2307/3579926 · 1998 · External reference
From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors
10.2967/jnumed.108.057307 · 2009 · External reference
Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0
10.1148/radiol.2016142043 · 2016 · External reference
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
10.1016/j.ejca.2008.10.026 · 2009 · External reference
Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques
10.1001/jamaoncol.2017.0973 · 2017 · External reference
Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
10.1007/s00066-015-0854-y · 2015 · External reference
Reirradiation of recurrent and second primary head and neck cancer with proton therapy
10.1016/j.ijrobp.2016.07.037 · 2016 · External reference
Reirradiation of head and neck cancers with proton therapy: outcomes and analyses
10.1016/j.ijrobp.2016.03.053 · 2016 · External reference
Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes
10.1016/j.ijrobp.2016.02.036 · 2016 · External reference
Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer
10.1111/ajco.12502 · 2017 · External reference
Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy
10.1007/s00066-017-1129-6 · 2017 · External reference
Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI collaborative
10.1016/j.ijrobp.2017.06.012 · 2018 · External reference
Feasibility of re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy
10.1016/j.radonc.2019.04.007 · 2019 · External reference
Intensity-modulated radiotherapy-based reirradiation for head and neck cancer: a multi-institutional study by Korean Radiation Oncology Group (KROG 1707)
10.4143/crt.2020.310 · 2020 · External reference
RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck
10.1016/s0360-3016(01)01745-x · 2001 · External reference
10.1007/0-306-48060-3_7
10.1007/0-306-48060-3_7 · 2004 · External reference
Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial
10.1016/j.ijrobp.2004.08.020 · 2005 · External reference
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
10.1016/j.radonc.2006.02.003 · 2006 · External reference
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911
10.1200/jco.2006.07.9194 · 2007 · External reference
Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol
10.1007/s00066-010-2082-9 · 2010 · External reference
Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck: A prospective phase II trial
10.1007/s00066-011-0040-9 · 2012 · External reference
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck
10.1016/j.ijrobp.2014.11.023 · 2015 · External reference
Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck
10.1093/annonc/mdy018 · 2018 · External reference
Beyond reirradiation: efficacy and safety of three or more courses of radiation for head and neck malignancies
10.1016/j.ctro.2020.04.009 · 2020 · External reference
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
10.1056/nejmoa1602252 · 2016 · External reference
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
10.1016/s0140-6736(18)31999-8 · 2019 · External reference
Unresolved reference
2025 · External reference
Hyperbaric oxygen therapy for late radiation tissue toxicity injury after head and neck cancer: a systematic review of the literature
10.1186/s13014-025-02680-1 · 2025 · External reference
Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations
10.1016/j.jocn.2012.09.011 · 2013 · External reference
Cerebral radiation necrosis
10.1111/ajco.12124 · 2014 · External reference
A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations
10.1016/j.ijrobp.2023.07.015 · 2024 · External reference
